Sequencing Platforms
& Multiomics Technology
Platforms
Short-Read Sequencing
Illumina NovaSeq™ X Plus
The Illumina NovaSeq™ X Plus brings unmatched scale and speed to short-read sequencing. Powered by X-LEAP chemistry and ultra-high-density patterned flow cells, the system delivers massive throughput with exceptional data quality—enabling everything from targeted studies to large genome-wide association projects. With its ability to generate vast amounts of sequencing data in a single run, NovaSeq X Plus helps accelerate discovery and turn research into actionable insights.
At Admera Health, we leverage NovaSeq X Plus to provide scalable, high-throughput sequencing across a wide range of applications, supporting both exploratory studies and large cohort projects. As a CLIA-certified and CAP-accredited laboratory, we also offer clinical-grade sequencing assays, including whole genome sequencing, ensuring projects are powered by the highest data quality standards.
Illumina NovaSeq™ 6000
The Illumina NovaSeq™ 6000 is built for high-throughput, large-scale sequencing, delivering up to 3 trillion bases in a single run. With flexible flow cell configurations—most notably the high-output S4 flow cell offering up to 2–2.5 billion read pairs (600–750 Gb) per lane—the NovaSeq 6000 supports everything from deep sequencing to expansive cohort studies.
At Admera Health, optimized workflows ensure fast turnaround and exceptional data quality, ideal for whole genomes, exomes, transcriptomes, and large custom panels. Multiple lane and read-length configurations are available to match your project scale and budget.
In our CLIA-certified and CAP-accredited laboratory, we also provide clinical-grade whole genome sequencing, in addition to research-use-only (RUO) services—giving researchers and clinicians access to reliable, high-throughput short-read sequencing backed by trusted quality standards.
Illumina NextSeq™ 1000/2000
The Illumina NextSeq™ 1000 and 2000 systems bring flexibility and scalability to mid-throughput sequencing projects. With support for multiple flow cell types and read lengths, these platforms deliver up to 400 million reads (120 Gb) per run, making them ideal for applications such as RNA-seq, whole-exome sequencing, targeted panels, and microbial genomics.
Designed with efficiency in mind, the NextSeq 1000/2000 combines advanced optics and patterned flow cell technology to provide faster turnaround times and high-quality data across a broad range of study sizes.
At Admera Health, we leverage the NextSeq platform to offer both cost-effective, smaller-scale sequencing and scalable workflows that can bridge into larger projects on NovaSeq or Revio.
Illumina MiSeq™
The Illumina MiSeq™ platform is a cost-effective solution for smaller-scale sequencing projects, offering high accuracy and flexible run formats. It’s ideal for amplicon sequencing, microbial genomes, targeted panels, and pilot studies where precision and quick turnaround matter.
With multiple configuration options—2×150 bp (4.5 Gb), 2×250 bp (7.5 Gb), and 2×300 bp (up to 13 Gb)—MiSeq provides the read length and depth needed for focused applications without overspending on throughput.
At Admera Health, MiSeq sequencing is integrated into our broader NGS workflow, allowing projects to easily scale to NextSeq or NovaSeq platforms when needed. Researchers benefit from reliable results, optimized protocols, and seamless support for both exploratory and validation studies.
Long-Read Sequencing
PacBio Revio™
The PacBio Revio™ platform delivers a major leap in throughput and efficiency for HiFi long-read sequencing. With up to 360 Gb of HiFi data in a single day and 15x greater output than previous systems, Revio enables large-scale projects without compromising accuracy. Its 25 million ZMW SMRT® Cell design allows up to four cells to run in parallel, providing 30x human genome coverage from just one cell.
Combining long read lengths (up to 25 kb) with >99.9% accuracy, Revio supports a broad range of applications—from de novo genome assembly and variant detection to single-cell transcriptomics and epigenetic analysis.
As a PacBio Certified Service Provider, Admera Health empowers researchers to harness the full potential of Revio, delivering high-throughput, high-accuracy sequencing that goes far beyond the limits of short-read technologies.
Single-Cell & Spatial Transcriptomics
10x Genomics Chromium™ X
The 10x Genomics Chromium™ X platform at Admera Health advances single-cell and multiomic sequencing with a scalable, higher-throughput evolution of the original 10x microfluidics system. It supports a broad range of assays, including single-cell gene expression, immune profiling, ATAC, Multiome (ATAC + Gene Expression), and Flex assays for fixed samples.
With compatibility across fresh, frozen, and fixed cells and tissues, Chromium X enables targeted gene expression, immune repertoire analysis, and multiomic discovery with exceptional flexibility and efficiency.
Admera Health leverages this platform to deliver advanced single-cell capabilities and customizable workflows that serve both research and translational applications.
10x Genomics Visium CytAssist™
The Visium CytAssist™ instrument streamlines spatial transcriptomics by enabling seamless transfer of tissue sections from standard glass slides onto Visium slides for downstream processing. This benchtop device improves consistency, preserves tissue integrity, and supports both FFPE and fresh frozen samples, making it easier to integrate spatial profiling into existing histology and molecular workflows.
By enhancing tissue handling and assay precision, CytAssist enables applications in transcriptomics, biomarker discovery, oncology, immunology, and developmental research with greater reliability and reproducibility.
Admera Health incorporates CytAssist into its Visium HD workflows to deliver standardized, high-quality spatial gene expression data across a wide range of sample types.
Takara Bio ICELL8® Shasta Single-Cell System
The Takara Shasta single-cell platform provides a highly scalable and flexible solution for single-cell analysis, enabling researchers to capture and profile tens of thousands of cells in a single run. Using advanced microfluidics and imaging-based cell selection, Shasta ensures precise single-cell isolation, minimal doublets, and compatibility with diverse cell types.
This system supports a wide range of applications, including single-cell RNA sequencing, immune profiling, and multiomic workflows, while offering the flexibility to process both suspension and challenging sample types. Its ability to pair high-throughput cell capture with reliable barcoding makes it an ideal tool for exploring cellular heterogeneity at scale.
At Admera Health, we integrate the Takara Shasta into our single-cell service portfolio, delivering efficient, customizable workflows that provide researchers with deep biological insights and high-quality data tailored to their study goals.
Our Certified Partnerships
Work with a Certified Service Provider for optimal NGS results